ID   DLKP-Mitox
AC   CVCL_4U31
SY   DLKP-MITOX
DR   Wikidata; Q54831183
RX   PubMed=15239124;
RX   PubMed=17593620;
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Omics: Proteome analysis by 2D-DE/MS.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H737 ! DLKP
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 10
//
RX   PubMed=15239124; DOI=10.1002/ijc.20230;
RA   Liang Y.-Z., O'Driscoll L., McDonnell S., Doolan P., Oglesby I.,
RA   Duffy K., O'Connor R., Clynes M.;
RT   "Enhanced in vitro invasiveness and drug resistance with altered gene
RT   expression patterns in a human lung carcinoma cell line after pulse
RT   selection with anticancer drugs.";
RL   Int. J. Cancer 111:484-493(2004).
//
RX   PubMed=17593620;
RA   Murphy L., Clynes M., Keenan J.;
RT   "Proteomic analysis to dissect mitoxantrone resistance-associated
RT   proteins in a squamous lung carcinoma.";
RL   Anticancer Res. 27:1277-1284(2007).
//